Fundraising Fox
Specificbiologics
Founded 2017 · 16 employees on LinkedIn · 1 known investors
Find your way into Specificbiologics
Sign up to see every warm intro you have to Specificbiologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Specificbiologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Specific Biologics develops in vivo genome editing therapeutics based on its Dualase editors, which use a two-site mechanism to remove, repair, or insert DNA sequences, with an initial focus on correcting expanded DNA repeats. Its pipeline targets CNS, lung, and liver genetic diseases using single AAV or lipid nanoparticle/polymer-encapsulated all-RNA delivery.
Investors · 1
Related companies · 2
CellectisCellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
BioCyticsBioCytics conducts translational cancer research, including a project with UNC Charlotte and Carolina BioOncology Institute to study the "dark genome" of cancer cells to identify sequences involved in tumor growth, immune response, and treatment response. Its work spans cell therapy, neoantigens, tumor infiltrating lymphocytes, and clinical research informatics.
Companies working in the same space as Specificbiologics.
Frequently asked questions
- What does Specificbiologics do?
- Specific Biologics develops in vivo genome editing therapeutics based on its Dualase editors, which use a two-site mechanism to remove, repair, or insert DNA sequences, with an initial focus on correcting expanded DNA repeats. Its pipeline targets CNS, lung, and liver genetic diseases using single AAV or lipid nanoparticle/polymer-encapsulated all-RNA delivery.
- Who are Specificbiologics's investors?
- Specificbiologics's investors include Lumira Ventures.